Technical feasibility studies compared quantitative mRNA levels of ER, PR, and human epidermal growth factor receptor 2 (HER-2), as assessed by qRT-PCR, with their respective protein levels determined using standard IHC-based assays in 62 breast cancer FFPE tumour specimens. The gene discussed is PGR; the disease is neoplasm.